Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/8993001

J. Immunol. 1997 Jan 15 158 2 834-41

Download in:

View as

General Info

PMID
8993001